Award

Delivery Order #SPE2D326F256H

DLA Orders Solu-Medrol Vials from Pfizer

Buyer

Defense Logistics Agency

Award Amount

$628.96

Ceiling

$628.96

Awarded

July 13, 2026

Period of Performance

Jul 13, 2026 – Jul 14, 2026

Identifier

SPE2D326F256H

NAICS

325412

This delivery order under a Defense Logistics Agency (DLA) indefinite-delivery contract directs Pfizer Inc. to supply Solu-Medrol 125 mg vials, an injectable corticosteroid medicine used to treat conditions requiring inflammation control. The order supports the DLA’s procurement of pharmaceutical products for government needs, including military health readiness. Pfizer is a pharmaceutical manufacturer and distributor. The parent contract, awarded through competitive bidding, provides for pharmaceutical supply over a long-term period; the available record does not identify the competition method for this individual order. The order covers the specified medication, with performance in New York, and a very short delivery period. No solicitation details, acquisition program, subcontractor information, or related prior orders are provided.

Description

4572360695!SOLU-MEDROL 125 MG VIALS

View original record